Detailed answers about NEFRO AVILLION CLINICAL DEVELOPMENT, LLC, including incorporation, status, business activity, and accounts information.
When was NEFRO AVILLION CLINICAL DEVELOPMENT, LLC founded?
NEFRO AVILLION CLINICAL DEVELOPMENT, LLC was officially incorporated on 1 May 2025 and is registered under company number FC043606. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is NEFRO AVILLION CLINICAL DEVELOPMENT, LLC?
Oversea Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of NEFRO AVILLION CLINICAL DEVELOPMENT, LLC?
NEFRO AVILLION CLINICAL DEVELOPMENT, LLC's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What is NEFRO AVILLION CLINICAL DEVELOPMENT, LLC's registered address?
The registered office address of NEFRO AVILLION CLINICAL DEVELOPMENT, LLC is Corporation Service Company, 251 Little Falls Drive, Wilmington, New Castle County 19808, United States. This is the official address filed with Companies House for legal and statutory correspondence.
Is NEFRO AVILLION CLINICAL DEVELOPMENT, LLC financially stable?
Financial accounts for NEFRO AVILLION CLINICAL DEVELOPMENT, LLC are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.